Abstract
The mechanisms by which growth factors trigger signal transduction pathways leading to the regulation of c-Fos expression are of great interest. In this study we investigated the effect of hepatocyte growth factor (HGF/SF) and epidermal growth factor (EGF) on the expression of c-fos and its product, c-Fos, in human epithelial cell line MKN74. The expression level of c-Fos protein in HGF/SF-stimulated cells was 5--10-fold higher than that in EGF-stimulated cells, whereas the level of c-fos mRNA induced by HGF/SF was similar to that by EGF. The hyperphosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), indicative of an increased number of translation initiation complexes, was detected only in HGF/SF-induced MKN74 cells. Activation of phosphatidylinositol-3'-OH kinase and FKBP12-rapamycin associated mammalian target of rapamycin (FRAP/mTOR) was observed after the treatment with HGF/SF. Pretreatment with an inhibitor of either one, i.e. LY294002 for phosphatidylinositol-3'-OH kinase or rapamycin for FRAP/mTOR, completely inhibited 4E-BP1 phosphorylation and decreased the c-Fos synthesis induced by HGF/SF down to the level found in EGF-induced cells. These results suggest that the phosphorylation of 4E-BP1 is stimulated by HGF/SF in a manner requiring both phosphatidy-linositol-3'-OH kinase-dependent and FRAP/mTOR-dependent pathways, thereby stimulating c-fos mRNA translation. Regulation of the translation process of c-fos mRNA in addition to the immediate activation of c-fos transcription is necessary for the transient increase in the level of c-Fos protein to stimulate cell proliferation.
Highlights
C-Fos, a transcription factor, is a product of a member of the immediate-early gene family and heterodimerizes with a transcription factor of the Jun family
In this study we investigated the effect of hepatocyte growth factor (HGF/SF) and epidermal growth factor (EGF) on the expression of c-fos and its product, c-Fos, in human epithelial cell line MKN74
Pretreatment with an inhibitor of either one, i.e. LY294002 for phosphatidylinositol-3-OH kinase or rapamycin for FRAP/mTOR, completely inhibited 4E-binding protein 1 (4E-BP1) phosphorylation and decreased the c-Fos synthesis induced by HGF/SF down to the level found in EGF-induced cells
Summary
C-Fos, a transcription factor, is a product of a member of the immediate-early gene family and heterodimerizes with a transcription factor of the Jun family. Pretreatment with an inhibitor of either one, i.e. LY294002 for phosphatidylinositol-3-OH kinase or rapamycin for FRAP/mTOR, completely inhibited 4E-BP1 phosphorylation and decreased the c-Fos synthesis induced by HGF/SF down to the level found in EGF-induced cells. We compared HGF/SF- and EGF-induced c-fos mRNA levels to examine the upstream response of MKN74 cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have